Reducción en investigación de nuevas terapias CV: Por qué? https://t.co/5hkquewX0v
RT @JACCJournals: Why is there decline in medical innovation for new CVD therapeutics? How do we combat this? #JACCBTS #openaccess https://…
RT @JACCJournals: Why is there decline in medical innovation for new CVD therapeutics? How do we combat this? #JACCBTS #openaccess https://…
RT @JACCJournals: Why is there decline in medical innovation for new CVD therapeutics? How do we combat this? #JACCBTS #openaccess https://…
RT @JACCJournals: Why is there decline in medical innovation for new CVD therapeutics? How do we combat this? #JACCBTS #openaccess https://…
RT @JACCJournals: Why is there decline in medical innovation for new CVD therapeutics? How do we combat this? #JACCBTS #openaccess https://…
Why is there decline in medical innovation for new CVD therapeutics? How do we combat this? #JACCBTS #openaccess https://t.co/7wu74Qe5C6 https://t.co/lRXsbnMsI3